Search
170 studies match these filters. Showing 51–75 of 170 studies
| Registration number | Study | Status | Phase | Enrolment | Sites / countries | Start year | Last updated | Actions |
|---|---|---|---|---|---|---|---|---|
| NCT04267848 | Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immun… ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 1,151 sites in total | Recruiting | Phase 3 | 1,210target | 1,151 / 2 | 2020 | Nov 12, 2026 | |
| NCT06510374 | Trial of Nadofaragene Firadenovec vs. Observation in Participants With Intermediate Risk Non-Muscle Invasive Bladder Cancer A phase 3b, Randomized, Controlled Trial of Nadofaragene Firadenovec vs. Observation in Participants with Intermediate Risk Non-Muscle Invasive Bladder Cancer (IR NMIBC) ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 119 sites in total | Recruiting | Phase 3 | 454target | 119 / 10 | 2024 | Nov 12, 2026 | |
| NCT07919678 | A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1) The purpose of this clinical study is to learn about the safety and effects of berobenatide (PF-08653944) for the treatment of knee osteoarthritis in adults with overweight or obesity. The study will last 52 weeks and compare the effects of berobenatide compared to placebo on knee pain, physical fun… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 40 sites in total | Recruiting | Phase 3 | 656target | 40 / 2 | 2026 | Nov 5, 2026 | |
| NCT07155005 | Stone Clearance With Aspiration vs Other Technologies: a Real-world Evidence Study The goal of this clinical trial is to evaluate the effectiveness and safety of Steerable Ureteroscopic Renal Evacuation (SURE) with the CVAC System versus other commonly used renal-stone interventions. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 10 sites in total · contact listed | Recruiting | 1,000target | 10 / 1 | 2026 | Nov 2, 2026 | ||
| NCT03435796 | Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells This is a prospective study for the long-term follow-up (LTFU) of safety and efficacy for all pediatric and adult participants exposed to Gene-modified (GM) T-cell therapy participating in a previous Celgene sponsored or Celgene alliance partner sponsored study. Participants who received at least o… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 225 sites in total · contact listed | Recruiting | Phase 2 / Phase 3 | 1,541target | 225 / 23 | 2018 | Nov 2, 2026 | |
| NCT06932263 | Dose Range Finding Study to Assess Efficacy and Safety of Tozorakimab in Adults With Uncontrolled Asthma on Medium-to-High Dose Inhaled Corticosteroids This is a dose-range finding, double-blind, placebo-controlled, phase IIb study designed to assess efficacy and safety of tozorakimab administered subcutaneously in adult participants with uncontrolled asthma receiving medium-to-high dose inhaled corticosteroids. ✓ Contact✗ Claimed Nearest site: Hutchinson, Kansas, United States — 36 km away · 223 sites in total | Recruiting | Phase 2 | 540target | 223 / 21 | 2025 | Oct 30, 2026 | |
| NCT07784725 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment ✓ Contact✗ Claimed Nearest site: El Dorado, Kansas, United States — 85 km away · 220 sites in total | Recruiting | Phase 3 | 2,500target | 220 / 16 | 2026 | Oct 30, 2026 | |
| NCT06172296 | Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma This phase III trial tests how well the addition of dinutuximab to Induction chemotherapy along with standard of care surgical resection of the primary tumor, radiation, stem cell transplantation, and immunotherapy works for treating children with newly diagnosed high-risk neuroblastoma. Dinutuximab… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 180 sites in total · contact listed | Recruiting | Phase 3 | 478target | 180 / 5 | 2024 | Oct 30, 2026 | |
| NCT07037459 | Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity This trial will examine if maridebart cafraglutide as an adjunct to standard of care will lead to a reduction in heart failure (HF) events such as HF hospitalizations and urgent HF visits, cardiovascular (CV) deaths and improvement in HF symptoms in participants with HF with preserved ejection fract… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 686 sites in total | Recruiting | Phase 3 | 5,056target | 686 / 35 | 2025 | Oct 29, 2026 | |
| NCT06190717 | Maturation of Arteriovenous Fistula With Automated Sonography Assessments Trial This is a prospective, multi-center, two-arm, randomized trial to quantify the performance of the EchoMark®/EchoSure® System for AVF diagnostic ultrasound when used under a protocol of biweekly use for assessing fistula maturation and reducing time to Clinical Maturation. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total · contact listed | Recruiting | Not applicable | 304target | 23 / 1 | 2024 | Oct 28, 2026 | |
| NCT07784270 | A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight The study will evaluate how well AZD6234 works and how safe it is in adults with excess weight or obesity. Efficacy of AZD6234 will be compared to placebo in percent body weight change from baseline at 68 weeks of treatment ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 230 sites in total | Recruiting | Phase 3 | 1,500target | 230 / 16 | 2026 | Oct 28, 2026 | |
| NCT05922878 | Study of ALTO-300 in MDD The purpose of this study is to determine efficacy differences between ALTO-300 and placebo, used adjunctively to an antidepressant, related to patient characteristics. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 75 sites in total | Recruiting | Phase 2 | 325target | 75 / 1 | 2023 | Oct 26, 2026 | |
| NCT07097142 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study This phase III trial compares the effect of decreased number of radiation (ultra-hypofractionated) treatments to the usual radiation number of treatments (hypofractionation) with standard of care chemotherapy, with cisplatin, gemcitabine or mitomycin and 5-fluorouracil for the treatment of patients… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 259 sites in total · contact listed | Recruiting | Phase 3 | 486target | 259 / 2 | 2025 | Oct 23, 2026 | |
| NCT05946213 | Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer This phase III trial compares stereotactic body radiation therapy (SBRT), (five treatments over two weeks using a higher dose per treatment) to usual radiation therapy (20 to 45 treatments over 4 to 9 weeks) for the treatment of high-risk prostate cancer. SBRT uses special equipment to position a pa… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 436 sites in total | Recruiting | Phase 3 | 1,500target | 436 / 5 | 2023 | Oct 23, 2026 | |
| NCT07045194 | Virtue® SAB in the Treatment of Coronary ISR Trial A prospective, multi-center, single-blind, randomized (1:1), non-inferiority study comparing clinical outcomes of the Virtue® Sirolimus AngioInfusion™ Balloon (SAB) to the AGENT™ Paclitaxel Drug-Coated Balloon (DCB) in the treatment of coronary artery in-stent restenosis (ISR). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed | Recruiting | Not applicable | 740target | 22 / 1 | 2025 | Oct 22, 2026 | |
| NCT07662213 | A Study to Find Out if the Study Drug Elecoglipron Helps Adults With Type 2 Diabetes Mellitus by Comparing it With Semaglutide, a Medicine Already Used to Treat Type 2 Diabetes Mellitus The purpose of this study is to evaluate the efficacy, safety, and tolerability of elecoglipron compared with oral semaglutide in adults with T2DM and increased cardiovascular risk that is inadequately managed alone or on stable treatment with other background glucose-lowering medication(s). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 210 sites in total | Recruiting | Phase 3 | 1,200target | 210 / 15 | 2026 | Oct 22, 2026 | |
| NCT02474160 | Collection and Storage of Tissue and Blood Samples From Patients With Cancer This study collects and stores tissue and blood samples from patients with cancer. Collecting and storing samples of tissue and blood from patients with cancer to study in the laboratory may help scientists create new and better models to learn about cancer and to test new cancer drugs. ✓ Contact✗ Claimed Nearest site: Kingman, Kansas, United States — 28 km away · 140 sites in total | Recruiting | 5,000target | 140 / 1 | 2015 | Oct 22, 2026 | ||
| NCT06677060 | Phase III Study Investigating Heart Failure and Cardiovascular Death With Baxdrostat in Combination With Dapagliflozin Participants include men and women ≥ 40 years of age with T2DM, established CV disease, a history of HTN with an SBP of at least 130 mmHg at screening, who meet the predefined serum potassium level, and with at least one additional risk factor for HF. The study will include an optional pre-screenin… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 977 sites in total | Recruiting | Phase 3 | 11,300target | 977 / 35 | 2025 | Oct 21, 2026 | |
| NCT06535854 | Prevail Global Study The purpose of the study is to evaluate the clinical safety and efficacy of the Prevail DCB. ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 79 sites in total · contact listed | Recruiting | Not applicable | 1,205target | 79 / 9 | 2025 | Oct 21, 2026 | |
| NCT05655182 | A Study of BLB-201 RSV Vaccine in Infants and Children This Phase 1/2a trial is a randomized, placebo-controlled trial to evaluate the safety, tolerability and immunogenicity of two ascending doses (10\^6 PFU and 10\^7 PFU) of intranasal BLB-201 (a recombinant parainfluenza virus type 5) administered in infants (8-24 months of age) and children (18-59 m… ✓ Contact✗ Claimed Nearest site: Newton, Kansas, United States — 53 km away · 18 sites in total · contact listed | Recruiting | Phase 1 / Phase 2 | 137target | 18 / 1 | 2023 | Oct 21, 2026 | |
| NCT05913908 | EFS of the DUO System for Tricuspid Regurgitation The study is an early feasibility study to measure individual patient clinical outcomes and effectiveness, evaluate the safety and function of the DUO Transcatheter Tricuspid Coaptation Valve System (DUO System). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 18 sites in total · contact listed | Recruiting | Not applicable | 15target | 18 / 2 | 2024 | Oct 21, 2026 | |
| NCT05685433 | A Real World Study of eCoin for Urgency Urinary Incontinence: Post Approval Evaluation (RECIPE) A prospective, multicenter, single-arm study to evaluate the safety and effectiveness of the eCoin® implanted tibial nerve stimulator in subjects with urgency urinary incontinence (UUI). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 22 sites in total · contact listed | Recruiting | Not applicable | 200target | 22 / 1 | 2023 | Oct 19, 2026 | |
| NCT06297291 | Global Paradise System US Post Approval Study The objective of the Global Paradise® System US Post Approval Study (US GPS) is to evaluate the real-world use of the Paradise Ultrasound Renal Denervation System indicated for patients who are unable to lower their blood pressure with lifestyle changes and medication. This system is comprised of a… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 46 sites in total · contact listed | Recruiting | 1,000target | 46 / 1 | 2024 | Oct 16, 2026 | ||
| NCT07830719 | Dose-finding Study of YMI024 to Assess Efficacy, Safety, and Tolerability in Adults With Stable Coronary Artery Disease and Elevated hsCRP The purpose of this Phase 2b study is to investigate the efficacy in reducing systemic inflammation, safety, tolerability, and dose response of five doses of YMI024, as compared to placebo in adult participants with stable coronary artery disease (CAD) and residual inflammatory risk defined by eleva… ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 23 sites in total · contact listed | Recruiting | Phase 2 | 180target | 23 / 5 | 2026 | Oct 15, 2026 | |
| NCT06628908 | Evaluation of Efficacy and Safety of Suzetrigine for Pain Associated With Diabetic Peripheral Neuropathy The purpose of this study is to evaluate the efficacy, safety, and tolerability of Suzetrigine (SUZ) in participants with pain associated with diabetic peripheral neuropathy (DPN). ✓ Contact✗ Claimed Nearest site: Wichita, Kansas, United States — 43 km away · 76 sites in total | Recruiting | Phase 3 | 1,100target | 76 / 1 | 2024 | Oct 15, 2026 |